Abstracts

Citation

Using a composite maternal-infant outcome measure to assess the timing of TB preventive therapy in pregnant women.

Citation

Amita Gupta, Lisa Aaron, Grace Montepiedra, Gerhard Theron, Tsungai Chipato, Carolyne Onyango-Makkumbi, Lynda Stranix-Chibanda, Adriana Weinberg, IMPAACT P1078/TB APPRISE Study Team. Impact of maternal isoniazid preventive therapy (IPT) timing on acquisition of infant TB infection (TBI) in the IMPAACT P1078/TB APPRISE trial. Presented at: Union TB Meeting; 2018 Oct 25.

Citation

TP Mhembere, TG Mbengeranwa, T Vhembo, N Mufukari, MF Bwakura-Dangarembizi. Quantitative Adherence In Infants Receiving ARV Syrups: P1115 HFC Experience. Presented at: Adherence to HIV Prevention and Treatment Conference.

Citation

TG Mbengeranwa, T Vhembo, TP Mhembere, MF Bwakura-Dangarembizi. ART ADHERENCE IN PERINATALLY INFECTED INFANTS IN THE P1115 STUDY IN ZIMBABWE. Presented at: Adherence to HIV Prevention and Treatment Conference.

Citation

Shuk Hang (Grace) Li, M Dennis, J Eudailey, Y Fong, J Pollara, K Saunders, C LaBranche, D Montefiori, S Permar, G Fouda. Higher HIV neutralization breadth in young children than in chronically infected adults. Presented at: HIv Research for Prevention.

Citation

K Venkatesh, M Farhad, T Fenton, D Moodley, C Nakabiito, L Fairlie, MG Fowler, J Stringer, B Chi. Diagnostic accuracy of clinical newborn assessment versus ultrasound to define preterm birth: the PROMISE trial. Presented at: Society for Maternal-Fetal Medicine's Annual Meeting.

Citation

M Gockenbach, M Grimstein, Y Yang, J Momper, M Mirochnick, T Johnson, H Sachs for the Antiretrovirals in Pregnancy PBPK Modeling Group. PBPK MODELING OF RILPIVIRINE DURING PREGNANCY. Presented at: American Society for Clinical Pharmacology & Therapeutics.

Citation

X Liu, A Dallmann, T Cressey, M Mirochnick, J van den Anker, B Best, J Momper. A Physiologically-Based Pharmacokinetic Maternal-Fetal Model of Raltegravir and Dolutegravir. Presented at: American Society for Clinical Pharmacology & Therapeutics.

Citation

N Webb, N Tobin, G Aldrovandi. Diverse and extreme entry kinetics among vertically transmitted HIV-1 isolates. Presented at: CROI 2019; 2019 Mar 06.

Citation

D Burger, E Acosta, N van Ewijk, C Taylor, P Bollen, T Ruane, A Colbers, A Turkova, R Di Francesco, G Morse, R Browne. PROFICIENCY TESTING SUPPORTS COMBINED ANALYSIS OF DOLUTEGRAVIR PHARMACOKINETIC DATA. Presented at: CROI 2019.